IP Library Granted Patent US 8,003,790
Granted Patent B2
US 8,003,790 · App. 11/816,493 · Granted Aug 23, 2011

Salt of proline derivative, solvate thereof, and production method thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,003,790
App. No.
11/816,493
Granted
Aug 23, 2011
Kind
B2
Abstract

The present invention provides 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine (compound I) useful as a dipeptidyl peptidase-IV inhibitor, which has superior properties of stability and hygroscopicity, and reproducible crystal structure, and a production method thereof.

Claims (10)

1. The compound that is either 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine 2.5 hydrobromide or a hydrate thereof.

2. A method of producing 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine 2.5 hydrobromide or a hydrate thereof,

which comprises eliminating 1,1-dimethylethyloxycarbonyl from 3-{(2S,4S)-1-(1,1-dimethylethyloxycarbonyl)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine with hydrobromic acid, and simultaneously forming a salt.

3. A method of producing 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine 2.5 hydrobromide or a hydrate thereof,

which comprises crystallizing 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine 2.5 hydrobromide from water and/or a solvent selected from ethanol, 1-propanol, 2-propanol, ethyl acetate, and acetone.

4. The method of claim 2 , wherein the hydrate is a 1.0 to 2.0hydrate.

5. The method of claim 3 , wherein the hydrate is a 1.0 to 2.0 hydrate.

6. The compound of claim 1 , which is a hydrate of 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine 2.5 hydrobromide.

7. The compound of claim 6 , wherein the hydrate is a 1.0 to 2.0 hydrate.

8. The compound of claim 7 , which has peaks at diffraction angles represented by 2θ of 5.4°, 13.4° and 14.4° (each ±0.2°) in a powder X-ray diffraction pattern.

Assignments (2)
CHANGE OF NAME Recorded Apr 17, 2008
From: MITSUBISHI PHARMA CORPORATION
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 020838/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2007
From: YOSHIDA, TOMOHIRO; SAKASHITA, HIROSHI; UEDA, NAOKO; KIRIHARA, SHINJI; UEMORI, SATORU; TSUTSUMIUCHI, REIKO; AKAHOSHI, FUMIHIKO
To: MITSUBISHI PHARMA CORPORATION
Reel/Frame 019949/0734 →